Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Menopause and Environmental Toxin Avoidance: What the Evidence Actually Shows

By
Published Updated Last reviewed
8 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Menopause definition / 12 months in a row with no period [2]
  • Usual age at menopause / 45 to 55; US average 52 [2]
  • Chemical groups discussed / bisphenol A, phthalates, toxic metals, organochlorine pesticides [3][4]
  • Evidence for chemicals / animal models and correlational human data [1]
  • Best-evidenced treatment for hot flashes / hormone therapy [5]
  • Supplements and herbal remedies / not recommended for vasomotor symptoms [6]
  • Median duration of frequent hot flashes / 7.4 years [7]

What the research covers

A 2026 review of environmental toxins in autoimmune disease lists toxic metals such as mercury, lead, cadmium and arsenic, plus endocrine-disrupting chemicals like bisphenol A and phthalates, as substances that accumulate in tissue and disrupt immune homeostasis. It also states that hormonal fluctuations during puberty, pregnancy and menopause influence toxin metabolism and detoxification efficiency [3]. This is a proposed mechanism, and the review's focus is autoimmune disease, not hot flashes.

Organochlorine pesticides are described as estrogen-mimicking and flagged as a possible risk for hormone-dependent disease. In a study of 200 people in North India (100 women with epithelial ovarian cancer and 100 controls), blood levels of several organochlorine pesticides were higher in the cancer cases [4]. The outcome was ovarian cancer, not menopause timing or hot flashes.

What helps hot flashes

The Menopause Society's 2022 position statement says hormone therapy remains the most effective treatment for vasomotor symptoms and has been shown to prevent bone loss and fracture. For women younger than 60 or within 10 years of menopause onset without contraindications, it calls the benefit-risk ratio favorable for bothersome vasomotor symptoms [5].

Its 2023 nonhormone statement recommended cognitive-behavioral therapy, clinical hypnosis, SSRIs and SNRIs, gabapentin and fezolinetant on Level I evidence. It did not recommend paced respiration (Level I) or supplements and herbal remedies (Levels I-II) [6].

In the MENOS 2 trial, 140 women had 10 or more problematic hot flushes or night sweats a week for at least a month. Group CBT reduced the hot flush and night sweat problem rating versus no treatment by an adjusted mean difference of 2.12 points at 6 weeks (95% CI 1.36 to 2.88) [8].

How long symptoms last

Menopause is 12 months in a row without a period, and perimenopause lasts about four years on average and up to 10 years [2]. In SWAN, a study of 3,302 women at 7 US sites, frequent vasomotor symptoms lasted a median of 7.4 years, with a median of 4.5 years of persistence after the final menstrual period [7].

Frequently asked questions

What are endocrine-disrupting chemicals?
Environmental chemicals that affect the endocrine (hormone) system. A 2026 review names bisphenol A and phthalates as examples and lists toxic metals such as mercury, lead, cadmium and arsenic alongside them [3]. The Endocrine Society's 2015 statement found that animal models substantiate causal links, while human data are consistent but correlational [1].
Do hormonal changes at menopause affect how the body handles toxins?
A 2026 review states that hormonal fluctuations across puberty, pregnancy and menopause influence toxin metabolism and detoxification efficiency [3]. It describes this as a mechanism.
What is the strongest treatment for hot flashes?
The Menopause Society's 2022 position statement says hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause, and prevents bone loss and fracture [5]. For women under 60 or within 10 years of menopause onset without contraindications, it calls the benefit-risk ratio favorable [5].
Are supplements or herbal remedies recommended for menopause symptoms?
No. The Menopause Society's 2023 nonhormone position statement lists supplements and herbal remedies among the approaches it does not recommend, based on Level I-II evidence [6].

References

  1. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1-E150. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
  2. Menopause basics | Office on Women's Health. Menopause basics | Office on Women's Health
  3. Bjørklund G, Wallace DR, Kangarlou K, Hossain F, Peana M. Environmental toxins and toxic metals in autoimmune diseases: Sex differences, hormonal influences, and immune dysregulation. Autoimmun Rev. 2026;25(1):103955. Environmental toxins and toxic metals in autoimmune diseases: Sex differences, hormonal influences, and immune dysregulation
  4. Sharma T, Banerjee BD, Thakur GK, Guleria K, Mazumdar D. Polymorphism of xenobiotic metabolizing gene and susceptibility of epithelial ovarian cancer with reference to organochlorine pesticides exposure. Exp Biol Med (Maywood). 2019;244(16):1446-1453. Polymorphism of xenobiotic metabolizing gene and susceptibility of epithelial ovarian cancer with reference to organochlorine pesticides exposure
  5. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. The 2022 hormone therapy position statement of The North American Menopause Society
  6. New Collective Author. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590. The 2023 nonhormone therapy position statement of The North American Menopause Society
  7. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531-9. Duration of menopausal vasomotor symptoms over the menopause transition
  8. Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause. 2012;19(7):749-59. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial
Evidence overview for Menopause and Environmental Toxin Avoidance: What the Evidence Actually Shows